NCT03081949View on ClinicalTrials.gov

Peripartum Cardiomyopathy in Nigeria Registry

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 12, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

December 31, 2019

Conditions
Peripartum Cardiomyopathy
Interventions
DRUG

Oral Sodium Selenite 200 µg/day for 3 months

PPCM patients with selenium deficiency, who have not achieved LV reverse remodelling (LVRR) (LV end-diastolic dimension indexed to body surface area (LVEDDi) ≤33.0 mm/m2) at 6 months after diagnosis.

Trial Locations (2)

700233

Aminu Kano Teaching Hospital, Kano

Unknown

Aminu Kano Teaching Hospital, Kano

All Listed Sponsors
collaborator

Nigerian Cardiac Society

UNKNOWN

lead

Aminu Kano Teaching Hospital

OTHER

NCT03081949 - Peripartum Cardiomyopathy in Nigeria Registry | Biotech Hunter | Biotech Hunter